BR0010739A - Processo de análise da predisposição genética de um paciente a pelo menos uma doença e amplificação de uma sequência e de duas sequências - Google Patents

Processo de análise da predisposição genética de um paciente a pelo menos uma doença e amplificação de uma sequência e de duas sequências

Info

Publication number
BR0010739A
BR0010739A BR0010739-5A BR0010739A BR0010739A BR 0010739 A BR0010739 A BR 0010739A BR 0010739 A BR0010739 A BR 0010739A BR 0010739 A BR0010739 A BR 0010739A
Authority
BR
Brazil
Prior art keywords
disease
patient
polymorphic region
resolution
amplification
Prior art date
Application number
BR0010739-5A
Other languages
English (en)
Inventor
Bruno Mougin
Jean-Marie Tiercy
Original Assignee
Bio Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26234969&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0010739(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9906599A external-priority patent/FR2793808B1/fr
Application filed by Bio Merieux filed Critical Bio Merieux
Publication of BR0010739A publication Critical patent/BR0010739A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"PROCESSO DE ANáLISE DA PREDISPOSIçãO GENéTICA DE UM PACIENTE A PELO MENOS UMA DOENçA E AMPLIFICAçãO DE UMA SEQuêNCIA E DE DUAS SEQuêNCIAS". A presente invenção refere-se a um processo de análise da predisposição genética de um paciente a pelo menos uma doença. Ela consiste igualmente em uma amplificação adaptada a um tal processo. O processo consiste em colocar uma amostra líquida que contém pelo menos um tipo de amplicons, proveniente da amplificação de, pelo menos, uma região polimórfica de interesse em relação com a ou as doenças pesquisadas, em presença de sondas escolhidas da seguinte forma: pelo menos uma sonda específica de tipagem, dita com baixa resolução, capaz de se hibridizar na região polimórfica de interesse de, pelo menos, uma sonda específica de sub-tipagem, dita com alta resolução, a ou as sondas com alta resolução que permitem discriminar o ou os alelos associados com a susceptibilidade genética e/ou o ou os alelos associados à resistência a dita ou as ditas doenças, de acordo com sua hibridização ou sua não hibridização. A invenção encontrou uma aplicação preferencial no domínio dos diagnósticos.
BR0010739-5A 1999-05-20 2000-05-19 Processo de análise da predisposição genética de um paciente a pelo menos uma doença e amplificação de uma sequência e de duas sequências BR0010739A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9906599A FR2793808B1 (fr) 1999-05-20 1999-05-20 Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie
FR9915314A FR2793809B1 (fr) 1999-05-20 1999-12-06 Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie et amplification adaptee a un tel procede
PCT/FR2000/001385 WO2000071750A1 (fr) 1999-05-20 2000-05-19 Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie et amplification adaptee a un tel procede

Publications (1)

Publication Number Publication Date
BR0010739A true BR0010739A (pt) 2002-02-19

Family

ID=26234969

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010739-5A BR0010739A (pt) 1999-05-20 2000-05-19 Processo de análise da predisposição genética de um paciente a pelo menos uma doença e amplificação de uma sequência e de duas sequências

Country Status (12)

Country Link
US (1) US7060438B1 (pt)
EP (1) EP1179091B2 (pt)
JP (1) JP2003500067A (pt)
CN (1) CN1351672A (pt)
AT (1) ATE279535T1 (pt)
AU (1) AU772175B2 (pt)
BR (1) BR0010739A (pt)
CA (1) CA2374440A1 (pt)
DE (1) DE60014887T3 (pt)
ES (1) ES2230109T5 (pt)
FR (1) FR2793809B1 (pt)
WO (1) WO2000071750A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2829580B1 (fr) 2001-09-07 2004-02-13 Bio Merieux Procede de lecture, de detection ou de quantification, hybrides ou complexes utilises dans ce procede et biopuce mettant en oeuvre ledit procede
AU2003298655A1 (en) 2002-11-15 2004-06-15 Bioarray Solutions, Ltd. Analysis, secure access to, and transmission of array images
EP1536021A1 (en) * 2003-11-27 2005-06-01 Consortium National de Recherche en Genomique (CNRG) Method for HLA typing
US7848889B2 (en) * 2004-08-02 2010-12-07 Bioarray Solutions, Ltd. Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
FR2881437B1 (fr) 2005-01-31 2010-11-19 Biomerieux Sa Procede pour le diagnostic/pronostic d'un syndrome septique
FR2906537A1 (fr) 2006-09-28 2008-04-04 Biomerieux Sa Procede de diagnostic in vitro du cancer broncho-pulmonaire par detection des transcrits majoritaires alternatifs du gene klk8 codant la kallicreine 8 et son utilisation pour le pronostic de survie
BR112012027535B1 (pt) * 2010-04-27 2020-01-28 Fundacio Hospital Univ Vall Dhebron Institut De Recerca método in vitro para a detecção da susceptibilidade em desenvolver efeitos colaterais adversos relacionados com bioimplantes, uso de um kit e uso de antígenos como marcadores
JP5916718B2 (ja) 2010-06-04 2016-05-11 ビオメリューＢｉｏｍｅｒｉｅｕｘ 結腸直腸癌の予後判定のための方法及びキット
US9110079B2 (en) 2010-09-29 2015-08-18 Biomerieux Method and kit for establishing an in vitro prognosis on a patient exhibiting SIRS
WO2012129758A1 (en) 2011-03-25 2012-10-04 Biomerieux Method and kit for determining in vitro probability for individual to suffer from colorectal cancer
US10072300B2 (en) 2013-05-21 2018-09-11 Biomerieux Kit for the prognosis of colorectal cancer
EP3620984B1 (en) 2018-09-06 2024-04-10 Accenture Global Solutions Limited Digital quality control using computer visioning with deep learning

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567809A (en) * 1986-03-13 1996-10-22 Hoffmann-La Roche Inc. Methods and reagents for HLA DRbeta DNA typing
US5702885A (en) * 1990-06-27 1997-12-30 The Blood Center Research Foundation, Inc. Method for HLA typing
NL9002259A (nl) * 1990-10-17 1992-05-18 Eurodiagnostics B V Werkwijze voor het bepalen van een genotype door het vergelijken van de nucleotidensequentie van leden van een genfamilie, alsmede kit voor het opsporen van genetische variaties.
GB9024005D0 (en) 1990-11-05 1990-12-19 British Bio Technology Process for amplifying nucleic acid
FR2679252B1 (fr) * 1991-07-17 1993-12-10 Bio Merieux Systeme de sondes permettant d'effectuer le typage hla dr, et procede de typage utilisant lesdites sondes.
US5976789A (en) * 1991-07-17 1999-11-02 Bio Merieux System of probes enabling HLA-DR typing to be performed, and typing method using said probes
JPH0690757A (ja) * 1991-08-23 1994-04-05 Kitasato Inst:The Ｈｌａ−ｄｒタイピング用塩基配列群とそれを用いた ｈｌａ−ｄｒタイピング法
JPH08308596A (ja) * 1995-03-10 1996-11-26 Wakunaga Pharmaceut Co Ltd Ｈｌａの検出
US5939542A (en) 1995-03-10 1999-08-17 Wakunaga Seiyaku Kabushiki Kaisha Detection of HLA-DR
US6994958B2 (en) * 1995-11-29 2006-02-07 Anthony Nolan Bone Marrow Trust Methods for separating and/or identifying DNA molecules
FR2749308B1 (fr) * 1996-06-03 1998-07-24 Bio Merieux Sondes nucleotidiques et procede pour determiner le typage hla dqb1
US6287764B1 (en) * 1997-02-11 2001-09-11 William H. Hildebrand Class I sequence based typing of HLA-A, -B, and -C alleles by direct DNA sequencing
EP0887423A1 (en) * 1997-06-26 1998-12-30 Biotest Ag A method for determining the Histocompatibility locus antigen class II
EP1003917A1 (en) * 1997-08-11 2000-05-31 Visible Genetics Inc. Method and kit for hla class i typing dna
US5910413A (en) * 1997-10-10 1999-06-08 Visible Genetics, Inc. Method and kit for amplification, sequencing and typing of classical HLA class I genes

Also Published As

Publication number Publication date
EP1179091B2 (fr) 2009-02-25
DE60014887T2 (de) 2005-10-13
EP1179091B1 (fr) 2004-10-13
FR2793809B1 (fr) 2006-07-28
FR2793809A1 (fr) 2000-11-24
AU772175B2 (en) 2004-04-08
ES2230109T3 (es) 2005-05-01
CN1351672A (zh) 2002-05-29
CA2374440A1 (fr) 2000-11-30
WO2000071750A1 (fr) 2000-11-30
JP2003500067A (ja) 2003-01-07
EP1179091A1 (fr) 2002-02-13
US7060438B1 (en) 2006-06-13
ES2230109T5 (es) 2009-06-05
ATE279535T1 (de) 2004-10-15
DE60014887D1 (de) 2004-11-18
DE60014887T3 (de) 2009-09-24
AU4766000A (en) 2000-12-12

Similar Documents

Publication Publication Date Title
CN1896284B (zh) 一种鉴别等位基因类型的方法
LIU et al. Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders
Whitcombe et al. Detection of PCR products using self-probing amplicons and fluorescence
Álvarez-Iglesias et al. Coding region mitochondrial DNA SNPs: targeting east Asian and Native American haplogroups
US20060110765A1 (en) Detection of nucleic acid variation by cleavage-amplification (CleavAmp) method
EP1430150B1 (en) Diagnostic probe detection system
Leppers-Van de Straat et al. A novel PCR-based method for direct Fcγ receptor IIIa (CD16) allotyping
JP2009232850A (ja) 核酸を検出するためのプライマ伸長法
DK2412718T3 (en) CIRCUIT PRIMES USED BY NUCLEIC ACID AMPLIFICATION AND USE THEREOF
US8906620B2 (en) Exon grouping analysis
BR0010739A (pt) Processo de análise da predisposição genética de um paciente a pelo menos uma doença e amplificação de uma sequência e de duas sequências
Petersen et al. Short PNA molecular beacons for real-time PCR allelic discrimination of single nucleotide polymorphisms
Klintzsch et al. Detection of the nt230 [del4] MDR1 mutation in dogs by a fluorogenic 5′ nuclease TaqMan allelic discrimination method
JP2002516666A (ja) 少なくとも一つの特定のヌクレオチド配列の増幅方法及び使用されるプライマー
Faas et al. Sequence‐specific priming and exonuclease‐released fluorescence detection of HLA‐DQB1 alleles
US9637788B2 (en) Discrimination of blood type variants
Hayashi Recent enhancements in SSCP
Honeyman et al. Development of a snapback method of single-strand conformation polymorphism analysis for genotyping Golden Retrievers for the X-linked muscular dystrophy allele
KR20010051353A (ko) 변동된 종결 분석에 의한 핵산 서열의 변형 검출 방법
Tytgat et al. STRide probes: Single-labeled short tandem repeat identification probes
US20050244830A1 (en) Quantitative multiplex amplification on a genomic scale, and applications for detecting genomic rearrangements
Luo et al. Genotyping mitochondrial DNA single nucleotide polymorphisms by PCR ligase detection reactions
Attila et al. Prenatal diagnosis of sickle cell anemia in twin pregnancies and identification by VNTRs
KR20200070935A (ko) 참외의 품종 구별 및 f1 종자 순도검정을 위한 snp 기반 kasp용 프라이머 세트 및 이의 용도
Quek et al. Rapid carrier screening for β-thalassemia by single-step allele-specific PCR and detection

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]